Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04135586 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of a Physical Exercise Intervention During Neoadjuvant Chemotherapy in Women With Breast Cancer

Study acronym: NEOLIFE
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Nov 1, 2024 to Nov 1, 2026
    • Study completion date: Dec 1, 2024 to Dec 1, 2026
    v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Nov 1, 2021 to Nov 1, 2024
    • Study completion date: Jan 1, 2022 to Dec 1, 2024
    • Start date changed from estimate of Nov 1, 2019 to Jan 1, 2020
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To assess in women with triple-negative breast cancer receiving neo-adjuvant chemotherapy the effects of an intense physical exercise program (intervention group) on physical capacity, compared with a control group not meeting the minimum exercise recommendations of the World Health Organization (WHO).
Trial Details
NCT Number NCT04135586
Lead Sponsor Universidad Europea de Madrid
Conditions
(from sponsor)		 Physical Exercise
Related terms Motor Activity
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov